IRMA2: Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction

Sponsor
Hopital Foch (Other)
Overall Status
Terminated
CT.gov ID
NCT02948140
Collaborator
(none)
27
1
1
53.6
0.5

Study Details

Study Description

Brief Summary

The aim of the study is to estimate the contribution of abdominal imaging by magnetic resonance Imaging (MRI) and abdominal scanner in the detection of subdiaphragmatic infarction associated to the atrial fibrillation in the cerebral infarction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: MRI
  • Procedure: Abdominal scanner
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of New Diagnostic Methods of Cardio-embolic Related (Atrial Fibrillation) Cerebral Infarction
Actual Study Start Date :
Jun 13, 2016
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stroke

Procedure: MRI

Procedure: Abdominal scanner

Outcome Measures

Primary Outcome Measures

  1. Number of patients with subdiaphragmatic infarctions detected by abdominal MRI [14 days]

Secondary Outcome Measures

  1. Number of patients with subdiaphragmatic infarctions detected by abdominal scanner [14 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient over 18

  • Patient having a CHADS-VAsc Score ≥ 2;

  • Patient hospitalized for a secondary established ischemic accident in an atrial fibrillation not anticoagulated (INR<2 and/or receiving antiplatelet (aspirin, clopidogrel)) for less than 14 days;

  • Patient affiliated to a national insurance scheme or beneficiary

  • Patient having given a written consent

Exclusion Criteria:
  • Patient presenting cognitive disorders incompatible with the planned examinations (MRI / SCANNER).

  • Pacemaker or implantable defibrillator, or other contraindication in the MRI (metallic eye brightness, intra cerebral clip).

  • Contraindication in injected scanner.

  • Current pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Foch Suresnes France 92150

Sponsors and Collaborators

  • Hopital Foch

Investigators

  • Principal Investigator: Bertrand Lapergue, MD, Hôpital Foch

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Hopital Foch
ClinicalTrials.gov Identifier:
NCT02948140
Other Study ID Numbers:
  • 2016/02
  • 2016-A00020-51
First Posted:
Oct 28, 2016
Last Update Posted:
Feb 15, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Hopital Foch
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 15, 2021